Lauren Collins
- Department of Medicine
Assistant Professor
- (404) 616-6816
- lauren.frances.collins@emory.edu
- @lfcollins_md
Overview
Lauren F. Collins, MD, MSc is an Assistant Professor of Medicine in the Division of Infectious Diseases at Emory University. She is a graduate of the Boston University School of Medicine and completed her Internal Medicine residency at Duke University. She completed her Infectious Diseases fellowship and Master of Science in Clinical Research at Emory University.
Dr. Collins clinical and research interests focus on improving the care of persons with HIV and in particular, women with HIV and those affected by the Southern HIV/AIDS epidemic. In her research, she studies the mounting burden of non-AIDS comorbidities experienced by aging persons with HIV and specifically investigates the role of premature aging, sex differences, shared mechanistic drivers, and traditional and HIV-specific risk factors contributing to overall comorbidity burden. She is also interested in the clinical, service delivery and public health implications of coinfections affecting persons with HIV, namely chronic HCV and SARS-CoV-2.
She is a recent KL2 career development awardee supported by the Georgia Clinical and Translational Science Alliance and her project evaluates the use of a novel retinovascular imaging tool to explore microvascular dysfunction as a common pathogenesis and potential screening target of age-related comorbidities among women with and without HIV. Dr. Collins is also a co-investigator for the Womens Interagency HIV Study (WIHS) and the Emory Specialized Center of Research Excellence on Sex Differences (SCORE).
Academic Appointment
- Assistant Professor of Medicine, Division of Infectious Diseases, Emory University School of Medicine
Education
Degrees
- BS from University of Georgia
- MD from Boston University School of Medicine
- MSc from Emory University
Research
Publications
-
Hepatic Markers and Immunological Trajectories in a Cohort of Patients with HIV and Hepatitis C Virus Coinfection Treated with Direct-Acting Antivirals.
AIDS Res Hum Retroviruses
05/21/2025 Authors: Simoncini G; Li J; Mayer C; Collins LF; Battalora L; Buchacz K; HIV Outpatient Study Investigators -
Enhancing Hepatitis B Virus Vaccine Uptake and Immunity Through Long-Acting Antiretroviral Therapy Programmatic Synergy in the US South.
Open Forum Infect Dis Volume: 12 Page(s): ofaf096
03/01/2025 Authors: Ochieng E; Robinson V; Anderson E; Niles-Carnes L; Smith BL; Armstrong WS; Lora M; Colasanti JA; Collins LF -
Early Implementation of Long-Acting Injectable Cabotegravir for HIV Prevention in a Safety Net Hospital-based Primary Care Center in U.S. South.
02/11/2025 Authors: Baker D; Collins LF; Cantos VD; Hollenberg E; Kaplan A; Cowan T; Garcia J; Lora M -
Interest in and Preference for Long-acting Injectable Antiretroviral Therapy in the Era of Approved Cabotegravir/Rilpivirine Among Reproductive-aged Women in the US South.
Clin Infect Dis Volume: 80 Page(s): 164 - 167
02/05/2025 Authors: Collins LF; Sheth AN; Tisdale T; Mehta CC; Daniel G; Westreich D; Kassaye S; Topper EF; Konkle-Parker D; Rana A -
Policy Recommendations to Support Equitable Access to Long-Acting Injectables for Human Immunodeficiency Virus Prevention and Treatment: A Policy Paper of the Infectious Diseases Society of America and the HIV Medicine Association.
Clin Infect Dis
01/28/2025 Authors: Marcus JL; Weddle A; Kelley CF; Agwu A; Montalvo S; Sherman E; Vijayan T; Gutierrez J; Hickey MD; Dilworth SE -
Heterogeneous depressive symptom trajectories among women with type 2 diabetes: findings from the Women's Interagency HIV Study.
Ann Behav Med Volume: 59
01/04/2025 Authors: Perez NB; D'Eramo Melkus G; Fletcher J; Allen-Watts K; Jones DL; Collins LF; Ramirez C; Long A; Cohen MH; Merenstein D -
Comparative genomic analysis of emerging non-typeable Haemophilus influenzae (NTHi) causing emerging septic arthritis in Atlanta.
PeerJ Volume: 13 Page(s): e19081
01/01/2025 Authors: Bixler BJ; Royer CJ; Petit Iii RA; Moller AG; Sefton S; Thomas S; Tunali A; Collins LF; Farley MM; Satola SW -
Early Implementation and Outcomes Among People with HIV Who Accessed Long-Acting Injectable Cabotegravir/Rilpivirine at Two Ryan White Clinics in the U.S. South.
AIDS Res Hum Retroviruses Volume: 40 Page(s): 690 - 700
12/01/2024 Authors: Haser GC; Balter L; Gurley S; Thomas M; Murphy T; Sumitani J; Leue EP; Hollman A; Karneh M; Wray L -
Consequences of low-level viremia among women with HIV in the United States.
AIDS Volume: 38 Page(s): 1829 - 1838
11/01/2024 Authors: Aldredge A; Mehta CC; Lahiri CD; Schneider MF; Alcaide ML; Anastos K; Plankey M; French AL; Floris-Moore M; Tien PC -
Learning from the first: a qualitative study of the psychosocial benefits and treatment burdens of long-acting cabotegravir/rilpivirine among early adopters in three U.S. clinics.
J Int AIDS Soc Volume: 27 Page(s): e26394
11/01/2024 Authors: Christopoulos KA; Smith MB; Pareek P; Dawdani A; Erguera XA; Dance KV; Walker RS; Grochowski J; Mayorga-Munoz F; Hickey MD